Bupropion

Impax Hires Specialists to Help Sort Manufacturing Issues

Impax Hires Specialists to Help Sort Manufacturing Issues

By Zachary Brennan

Faced with manufacturing quality questions that caused the FDA to reject its potential Parkinson’s disease treatment, Impax Laboratories has hired a committee of specialists to oversee quality improvements at its California facility.

QuitPak enters pilot study

QuitPak enters pilot study

By Anna Lewcock

A combination therapy to help smokers kick the habit has begun
evaluation in Phase I pilot studies in the US. A sustained-release
formulation of Cary Pharmaceutical's QuitPak has been developed
with IntelGenx Technologies as...

Spotlight

Follow us

Webinars

Featured Suppliers

All